123 related articles for article (PubMed ID: 38290407)
1. The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance.
Gu J; Zhang J; Xia R; Wang X; Yang J; Xie F; Zhou Q; Li J; Zhang T; Chen Q; Fan Y; Guo S; Wang H
Drug Resist Updat; 2024 Mar; 73():101027. PubMed ID: 38290407
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner.
Li H; Peng C; Zhu C; Nie S; Qian X; Shi Z; Shi M; Liang Y; Ding X; Zhang S; Zhang B; Li X; Xu G; Lv Y; Wang L; Friess H; Kong B; Zou X; Shen S
Clin Epigenetics; 2021 Jan; 13(1):18. PubMed ID: 33499904
[TBL] [Abstract][Full Text] [Related]
3. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
Xu J; Liu S; Yang X; Cao S; Zhou Y
Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
[TBL] [Abstract][Full Text] [Related]
4. Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives.
Rahnama N; Jahangir M; Alesaeid S; Kahrizi MS; Adili A; Mohammed RN; Aslaminabad R; Akbari M; Özgönül AM
Pathol Res Pract; 2022 Aug; 236():153982. PubMed ID: 35779293
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance.
Gordon ER; Wright CA; James M; Cooper SJ
BMC Cancer; 2023 Jun; 23(1):524. PubMed ID: 37291514
[TBL] [Abstract][Full Text] [Related]
6. EIF5A regulates proliferation and chemoresistance in pancreatic cancer through the sHH signalling pathway.
Wang Z; Jiang J; Qin T; Xiao Y; Han L
J Cell Mol Med; 2019 Apr; 23(4):2678-2688. PubMed ID: 30761741
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway.
Lin C; Wang Y; Dong Y; Lai S; Wang L; Weng S; Zhang X
Biol Direct; 2022 Nov; 17(1):33. PubMed ID: 36397058
[TBL] [Abstract][Full Text] [Related]
8. KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer.
Yang K; Li Y; Lian G; Lin H; Shang C; Zeng L; Chen S; Li J; Huang C; Huang K; Chen Y
Int J Cancer; 2018 Jun; 142(11):2323-2334. PubMed ID: 29315556
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
[TBL] [Abstract][Full Text] [Related]
10. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer.
Hu Y; Wang F; Xu F; Fang K; Fang Z; Shuai X; Cai K; Chen J; Hu P; Chen D; Xu P; Hu C; Zeng Z; Zhong J; Li W; Tang J; Huang M; Zhao Y; Wang C; Zhao G
Theranostics; 2020; 10(22):10120-10140. PubMed ID: 32929338
[No Abstract] [Full Text] [Related]
11. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3.
Wan X; Guo D; Zhu Q; Qu R
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G309-G322. PubMed ID: 32463333
[TBL] [Abstract][Full Text] [Related]
12. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype.
El Amrani M; Corfiotti F; Corvaisier M; Vasseur R; Fulbert M; Skrzypczyk C; Deshorgues AC; Gnemmi V; Tulasne D; Lahdaoui F; Vincent A; Pruvot FR; Van Seuningen I; Huet G; Truant S
Mol Carcinog; 2019 Nov; 58(11):1985-1997. PubMed ID: 31373074
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of circular RNA expression profiles associated with gemcitabine resistance in pancreatic cancer cells.
Xu C; Yu Y; Ding F
Oncol Rep; 2018 Jul; 40(1):395-404. PubMed ID: 29781033
[TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.
Liu Y; Li X; Zhu S; Zhang JG; Yang M; Qin Q; Deng SC; Wang B; Tian K; Liu L; Niu Y; Wang CY; Zhao G
Gene Ther; 2015 Sep; 22(9):729-38. PubMed ID: 25965392
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin.
Xu J; Zhu W; Xu W; Yao W; Zhang B; Xu Y; Ji S; Liu C; Long J; Ni Q; Yu X
Curr Mol Med; 2013 Mar; 13(3):387-400. PubMed ID: 23331011
[TBL] [Abstract][Full Text] [Related]
19. miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance.
Deng X; Liu Z; Liu X; Fu Q; Deng T; Lu J; Liu Y; Liang Z; Jiang Q; Cheng C; Fang W
Mol Ther; 2018 Apr; 26(4):1066-1081. PubMed ID: 29525743
[TBL] [Abstract][Full Text] [Related]
20. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
